Annual report
4820.TEDINET S100XUIK
Period2025-01-01 → 2025-12-31
Filed2026-03-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥24.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2023-01-01 → 2023-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.9bn | 2022-01-01 → 2022-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.7bn | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥4.5bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥4.3bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.2bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.6bn | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.7bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.0bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥27.5bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥31.7bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥29.4bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥26.3bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.8bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.1bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥11.1bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.4bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥19.5bn | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥18.8bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.8bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.9bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.8bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥8.3bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.0bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.5bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥194m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥577m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥544m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥3.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥993m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.3bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥693m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥35.44 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.54 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.76 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.75 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.72 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥35.32 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥34.43 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.68 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.66 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.64 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥293.77 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥297.04 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥289.47 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥274.94 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥263.12 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 73.9% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.8% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.6% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.0% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.8% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.9% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 858 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 827 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 811 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 592 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 558 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥18.8bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥19.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥17.3bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.1bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.6bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.8bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥3.7bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥3.8bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.5bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.4bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.5bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.1bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥3.0bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥2.2bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥2.0bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥1.7bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.0bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥24.1bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥28.3bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥26.4bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥25.2bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥23.9bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.0bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥8.8bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥19.1bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥19.5bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥19.7bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥19.0bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥18.2bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.9bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.3bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥32.22 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.06 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.12 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.79 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.6 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥32.12 | 2025-01-01 → 2025-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.97 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.04 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.71 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.51 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥39 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥35 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥11 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥275.21 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥281.91 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥278.05 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥267.83 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥255.16 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 79.1% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.8% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.0% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.1% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.6% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.8% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 70,514,800 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 70,514,800 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,514,800 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,514,800 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,514,800 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 514 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 497 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 457 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 432 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 413 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 81
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-12-31 | 46 pure |
| Otherother segments | capex | 2025-01-01 → 2025-12-31 | ¥13m |
| Otherother segments | depreciation | 2025-01-01 → 2025-12-31 | ¥10m |
| Otherother segments | revenue | 2025-01-01 → 2025-12-31 | ¥1.1bn |
| Otherother segments | revenue external | 2025-01-01 → 2025-12-31 | ¥994m |
| Otherother segments | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥124m |
| Otherother segments | segment assets | at 2025-12-31 | ¥1.2bn |
| Otherother segments | segment profit | 2025-01-01 → 2025-12-31 | ¥28m |
| Reconciling Itemsreconciling | depreciation | 2025-01-01 → 2025-12-31 | ¥214m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-12-31 | −¥142m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-12-31 | −¥142m |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | ¥15.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | ¥27m |
| Care Welfare IT Systems Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥134m |
| Care Welfare IT Systems Businessreportable segment | employees | at 2025-12-31 | 61 pure |
| Care Welfare IT Systems Businessreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥566m |
| Care Welfare IT Systems Businessreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥566m |
| Care Welfare IT Systems Businessreportable segment | segment assets | at 2025-12-31 | ¥94m |
| Care Welfare IT Systems Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥378m |
| Medecl Computerreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥270m |
| Medecl Computerreportable segment | employees | at 2025-12-31 | 177 pure |
| Medecl Computerreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥2.9bn |
| Medecl Computerreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥2.9bn |
| Medecl Computerreportable segment | segment assets | at 2025-12-31 | ¥816m |
| Medecl Computerreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥32m |
| Pharmacy Receipt Computerreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥733m |
| Pharmacy Receipt Computerreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥860m |
| Pharmacy Receipt Computerreportable segment | employees | at 2025-12-31 | 533 pure |
| Pharmacy Receipt Computerreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥19.2bn |
| Pharmacy Receipt Computerreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥19.2bn |
| Pharmacy Receipt Computerreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥18m |
| Pharmacy Receipt Computerreportable segment | segment assets | at 2025-12-31 | ¥10.0bn |
| Pharmacy Receipt Computerreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥4.0bn |
| —segment total | capex | 2025-01-01 → 2025-12-31 | ¥1.2bn |
| —segment total | depreciation | 2025-01-01 → 2025-12-31 | ¥871m |
| —segment total | revenue | 2025-01-01 → 2025-12-31 | ¥23.8bn |
| —segment total | revenue external | 2025-01-01 → 2025-12-31 | ¥23.7bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥142m |
| —segment total | segment assets | at 2025-12-31 | ¥12.1bn |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | ¥3.6bn |
| Otherother segments | capex | 2024-01-01 → 2024-12-31 | ¥0 |
| Otherother segments | depreciation | 2024-01-01 → 2024-12-31 | ¥16m |
| Otherother segments | revenue | 2024-01-01 → 2024-12-31 | ¥1.2bn |
| Otherother segments | revenue external | 2024-01-01 → 2024-12-31 | ¥1.0bn |
| Otherother segments | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥152m |
| Otherother segments | segment assets | at 2024-12-31 | ¥1.0bn |
| Otherother segments | segment profit | 2024-01-01 → 2024-12-31 | ¥60m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥198m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥171m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥171m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥19.8bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | ¥22m |
| Care Welfare IT Systems Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥381m |
| Care Welfare IT Systems Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥171m |
| Care Welfare IT Systems Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥570m |
| Care Welfare IT Systems Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥570m |
| Care Welfare IT Systems Businessreportable segment | segment assets | at 2024-12-31 | ¥141m |
| Care Welfare IT Systems Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥450m |
| Medecl Computerreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥115m |
| Medecl Computerreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥193m |
| Medecl Computerreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥2.6bn |
| Medecl Computerreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥2.6bn |
| Medecl Computerreportable segment | segment assets | at 2024-12-31 | ¥797m |
| Medecl Computerreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥423m |
| Pharmacy Receipt Computerreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥627m |
| Pharmacy Receipt Computerreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥774m |
| Pharmacy Receipt Computerreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥20.7bn |
| Pharmacy Receipt Computerreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥20.7bn |
| Pharmacy Receipt Computerreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥19m |
| Pharmacy Receipt Computerreportable segment | segment assets | at 2024-12-31 | ¥9.9bn |
| Pharmacy Receipt Computerreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥5.3bn |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥1.1bn |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥1.2bn |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥25.0bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥24.8bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥171m |
| —segment total | segment assets | at 2024-12-31 | ¥11.8bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥4.4bn |
| Care Welfare IT Systems Businessreportable segment | employees | at 2025-12-31 | 43 pure |
| Medecl Computerreportable segment | employees | at 2025-12-31 | 136 pure |
| Pharmacy Receipt Computerreportable segment | employees | at 2025-12-31 | 306 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,661
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets per share (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 267.83 | |
| Net assets per share (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 278.05 | |
| Net assets per share (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 281.91 | |
| Net assets per share (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 275.21 | |
| Dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 11.00 | |
| Dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 12.00 | |
| Dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 14.00 | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 35.00 | |
| Dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 39.00 | |
| Interim dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 4.00 | |
| Interim dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 4.00 | |
| Interim dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 7.00 | |
| Interim dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 9.00 | |
| Interim dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 17.00 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 28.60 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 27.79 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 24.12 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 28.06 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 32.22 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 28.51 | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 27.71 | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 24.04 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 27.97 | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 32.12 | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 0.761 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 0.750 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 0.745 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.688 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 0.791 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 0.117 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 0.106 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.088 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.101 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.116 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 26.4 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 29.3 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 28.9 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 27.9 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 24.6 | |
| Payout ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 0.385 | |
| Payout ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 0.432 | |
| Payout ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.580 | |
| Payout ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 1.247 | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 1.210 | |
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 413 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 432 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 457 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 497 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 514 | |
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 50 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |